News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2019 Shelley Wood December 31, 2019
News Daily News Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD Michael O'Riordan December 10, 2019
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2019 Shelley Wood November 29, 2019
Presentation Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD November 14, 2019
News Conference News AHA 2019 More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA Michael O'Riordan November 14, 2019
News Opinion Off Script AHA 2019 Off Script: Will ISCHEMIA Answer Our Most Pressing Questions? Ajay Kirtane, MD, SM November 12, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Conference News AHA 2019 ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain Shelley Wood October 25, 2019
News Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia Michael O'Riordan September 24, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry Michael O'Riordan August 14, 2019
News Daily News Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis Shelley Wood July 23, 2019
News Daily News Nonobstructive CAD on Cardiac CTA a Golden Opportunity to Boost Statin Prescribing Michael O'Riordan July 22, 2019
News Industry News FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease July 15, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019